Market closed
Rapport Therapeutics, Inc./$RAPP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Rapport Therapeutics, Inc.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Ticker
$RAPP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
69
Website
RAPP Metrics
BasicAdvanced
$315M
-
-$3.78
-
-
Price and volume
Market cap
$315M
52-week high
$11.49
52-week low
$6.43
Average daily volume
335K
Financial strength
Current ratio
35.337
Quick ratio
34.821
Long term debt to equity
0.242
Total debt to equity
0.483
Management effectiveness
Return on assets (TTM)
-22.07%
Return on equity (TTM)
-35.09%
Valuation
Price to book
1.03
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
-2.662
Growth
Earnings per share change (TTM)
-83.66%
RAPP News
AllArticlesVideos
Crédit Agricole Ille-et-Vilaine : Communiqué de mise à disposition du rapport financier 2024
GlobeNewsWire·2 weeks ago
Bpce: Mise à disposition du document d'enregistrement universel 2024 et du rapport financier annuel du Groupe BPCE
GlobeNewsWire·3 weeks ago
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Rapport Therapeutics, Inc. stock?
Rapport Therapeutics, Inc. (RAPP) has a market cap of $315M as of April 12, 2025.
What is the P/E ratio for Rapport Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Rapport Therapeutics, Inc. (RAPP) stock is 0 as of April 12, 2025.
Does Rapport Therapeutics, Inc. stock pay dividends?
No, Rapport Therapeutics, Inc. (RAPP) stock does not pay dividends to its shareholders as of April 12, 2025.
When is the next Rapport Therapeutics, Inc. dividend payment date?
Rapport Therapeutics, Inc. (RAPP) stock does not pay dividends to its shareholders.
What is the beta indicator for Rapport Therapeutics, Inc.?
Rapport Therapeutics, Inc. (RAPP) does not currently have a Beta indicator.